rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

The Pennant Group, Inc.

PNTG · Nasdaq

Health CareProviders & FacilitiesLeading

PNTG stood above a rising 150-day average in 48 of the last 52 weekly readings, including each of the last 48 weeks. It is 12.4% above that average now. Providers & Facilities: 43% of its 53 stocks in an uptrend (−4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
48 in a row
Industry in uptrend
43% -4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$1.4M
Officials’ trades on record
0
Institutions holding
193 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.

20 Apr – 19 Oct
27%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$525K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months6
Buyers · sellers0 · 3
WhoDidSharesTraded
Kirk Sterling CheneyEVP, GC and Corp Secysold1,393at $38.526 Aug 2026filed 10 Aug 2026
Brent GuerisoliChief Executive Officersold4,285at $38.526 Aug 2026filed 10 Aug 2026
Jason Paul SteikChief Clinical Officersold1,394at $38.526 Aug 2026filed 10 Aug 2026
Brent GuerisoliChief Executive Officersold3,159at $41.5710 Jul 2026filed 14 Jul 2026
Brent GuerisoliChief Executive Officersold3,165at $40.517 Jul 2026filed 9 Jul 2026
Brent GuerisoliChief Executive Officersold22at $34.8622 May 2026filed 27 May 2026
Brent GuerisoliChief Executive Officersold2,032at $35.0822 May 2026filed 27 May 2026
Brent GuerisoliChief Executive Officersold200at $35.1022 May 2026filed 27 May 2026
Brent GuerisoliChief Executive Officersold2,254at $35.0822 May 2026filed 27 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders193+20 on the quarter
New · exited46 · 25
Reported value$1.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20262,959,141$109.3M+243,076+8.9%
WASATCH ADVISORS LPadded · filed 10 Jul 20261,870,178$69.1M+451,491+31.8%
TURTLE CREEK ASSET MANAGEMENT INC.added · filed 14 Aug 20261,714,462$63.3M+131,639+8.3%
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 20261,480,881$54.7M+1,480,881
PARADIGM CAPITAL MANAGEMENT INCreduced · filed 13 Aug 20261,402,800$51.8M-6,000−0.4%
FMR LLCadded · filed 13 Aug 20261,182,138$43.7M+79,514+7.2%
Provident Investment Management, Inc.reduced · filed 11 Aug 2026939,208$34.7M-43,807−4.5%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026891,426$32.9M+260,035+41.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026886,783$32.8M+44,645+5.3%
AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026874,745$32.3M+2,560+0.3%
31 Mar 2023 – 30 Jun 2026
102146190Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Barry M. Smith Company insiderDirector · last 15 Oct 20262 · 0
Christopher R. Christensen Company insiderDirector · last 15 Oct 20263 · 5
Gregory K. Morris Sr. Company insiderDirector · last 15 Oct 20260 · 0
John G. Nackel Company insiderDirector · last 15 Oct 20261 · 0
Scott E. Lamb Company insiderDirector · last 15 Oct 20262 · 0
Stephen M. R. Covey Company insiderDirector · last 15 Oct 20260 · 0
Suzanne D. Snapper Company insiderDirector · last 15 Oct 20260 · 0
Brent Guerisoli Company insiderChief Executive Officer · last 6 Aug 20260 · 7
Jason Paul Steik Company insiderChief Clinical Officer · last 6 Aug 20260 · 1
Kirk Sterling Cheney Company insiderEVP, GC and Corp Secy · last 6 Aug 20260 · 2
John J. Gochnour Company insiderChief Operating Officer · last 5 Mar 20261 · 0
Lynette Walbom Company insiderChief Financial Officer · last 5 Mar 20260 · 0

Same industry

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 20255.5%
Free cash flow marginFY 2025 · to 31 Dec 20253.8%
Return on capital employedFY 2025 · to 31 Dec 20256.3%
Cash conversionFY 2025 · to 31 Dec 2025163%
Debt to equityFY 2025 · to 31 Dec 20250.46×
Share count trendFY 2025 · to 23 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$17.0M
Free cash flowFY 2025 · to 31 Dec 2025$36.3M

Analyst forecasts

No analyst forecasts yet.